Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in ...
A case report describes two Chinese women with severe Danon disease initially suspected of cardiac amyloidosis, diagnosed ...
KEYTRUDA as Monotherapy Reduced Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent ...
Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement in ...
3dOpinion
Weekly Commentary: Need To Talk
South Korea's tech-heavy KOSPI dropped 2.8% Thursday, with Samsung down 4% and SK Hynix sinking 5.5%. Read more here.
However, the highest growth rate is recorded in numerically smaller sectors. Electricity and gas (+2.33%, equal to 364 businesses) and financial and insurance activities (+1.49%, +2,281 businesses) ...
(Adnkronos) - "The one from 80 years ago is not a closed chapter in our history: there are families who have lost loved ones and there are people injured as children, as well as those injured by ...
Rocket Lab Corporation may still be overvalued after a 66% drop. Click for more on RKLB stock and see if this is the right ...
Bayer Shares New Post Hoc Analysis Of Self-Reported Sleep-Related Outcomes with Lynkuet® (elinzanetant) in Women with Moderate to Severe Vasomotor Symptoms at the Menopause Socie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results